SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Rutherford Mark J.)
 

Search: WFRF:(Rutherford Mark J.) > (2020-2023) > Statistics on morta...

  • Alabas, Oras A.Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England (author)

Statistics on mortality following acute myocardial infarction in 842 897 Europeans

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • 2019-07-26
  • OXFORD UNIV PRESS,2020
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-404712
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-404712URI
  • https://doi.org/10.1093/cvr/cvz197DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142742534URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:149811053URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Aims: To compare ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) mortality between Sweden and the UK, adjusting for background population rates of expected death, case mix, and treatments.Methods and results: National data were collected from hospitals in Sweden [n = 73 hospitals, 180 368 patients, Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)] and the UK [n = 247, 662 529 patients, Myocardial Ischaemia National Audit Project (MINAP)] between 2003 and 2013. There were lower rates of revascularization [STEMI (43.8% vs. 74.9%); NSTEMI (27.5% vs. 43.6%)] and pharmacotherapies at time of hospital discharge including [aspirin (82.9% vs. 90.2%) and (79.9% vs. 88.0%), beta-blockers (73.4% vs. 86.4%) and (65.3% vs. 85.1%)] in the UK compared with Sweden, respectively. Standardized net probability of death (NPD) between admission and 1 month was higher in the UK for STEMI [8.0 (95% confidence interval 7.4-8.5) vs. 6.7 (6.5-6.9)] and NSTEMI [6.8 (6.4-7.2) vs. 4.9 (4.7-5.0)]. Between 6 months and 1 year and more than 1 year, NPD remained higher in the UK for NSTEMI [2.9 (2.5-3.3) vs. 2.3 (2.2-2.5)] and [21.4 (20.0-22.8) vs. 18.3 (17.6-19.0)], but was similar for STEMI [0.7 (0.4-1.0) vs. 0.9 (0.7-1.0)] and [8.4 (6.7-10.1) vs. 8.3 (7.5-9.1)].Conclusion: Short-term mortality following STEMI and NSTEMI was higher in the UK compared with Sweden. Mid- and longer-term mortality remained higher in the UK for NSTEMI but was similar for STEMI. Differences in mortality may be due to differential use of guideline-indicated treatments.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Jernberg, TomasKarolinska Institutet (author)
  • Pujades-Rodriguez, MarUniv Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England (author)
  • Rutherford, Mark J.Univ Leicester, Dept Hlth Sci, Leicester, Leics, England (author)
  • West, Robert M.Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England (author)
  • Hall, MarlousUniv Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, Sweden (author)
  • Timmis, AdamBarts Heart Ctr, Dept Cardiol, London, England (author)
  • Lindahl, Bertil,1957-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)belin227 (author)
  • Fox, Keith A. A.Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland (author)
  • Hemingway, HarryUCL, Hlth Data Res UK London, London, England;UCL, Inst Hlth Informat, London, England;UCL, Natl Inst Hlth Res, Univ Coll London Hosp, Biomed Res Ctr, London, England (author)
  • Gale, Chris P.Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, Sweden;Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England (author)
  • Karolinska InstitutetUniv Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England (creator_code:org_t)

Related titles

  • In:Cardiovascular Research: OXFORD UNIV PRESS116:1, s. 149-1570008-63631755-3245

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view